Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1791, Issue 10, 2009, Pages 1031-1036

  van Haperen, Rien ^a   Samyn, Hannelore ^a   van Gent, Teus ^a   Zonneveld, Adri J ^a   Moerland, Matthijs ^a   Grosveld, Frank ^a   Jansen, Hans ^a   Dallinga Thie, Geesje M ^b   van Tol, Arie ^a   de Crom, Rini ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cholesteryl ester; HL; PLTP; Triglyceride

Indexed keywords

CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; PHOSPHOLIPID TRANSFER PROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS BREEDING; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME RELEASE; GENE OVEREXPRESSION; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL; TURNOVER TIME;

ANIMALS; CHOLESTEROL, HDL; CHOLESTEROL, VLDL; LIPASE; LIPOPROTEIN LIPASE; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; PHOSPHOLIPID TRANSFER PROTEINS;

MUS; MUS MUSCULUS;

EID: 69949085009     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.06.001     Document Type: Article

References (32)

1. Huuskonen J., Olkkonen V.M., Jauhiainen M., and Ehnholm C. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis 155 (2001) 269-281
2. van Tol A. Phospholipid transfer protein. Curr. Opin. Lipidol. 13 (2002) 135-139
3. von Eckardstein A., Jauhiainen M., Huang Y., Metso J., Langer C., Pussinen P., Wu S., Ehnholm C., and Assmann G. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL. Biochim. Biophys. Acta 1301 (1996) 255-262
4. Van Haperen R., Van Tol A., Van Gent T., Scheek L., Visser P., Van Der Kamp A., Grosveld F., and De Crom R. Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. J. Biol. Chem. 277 (2002) 48938-48943
5. Kawano K., Qin S.C., Lin M., Tall A.R., and Jiang X. Cholesteryl ester transfer protein and phospholipid transfer protein have nonoverlapping functions in vivo. J. Biol. Chem. 275 (2000) 29477-29481
6. Lie J., de Crom R., Jauhiainen M., van Gent T., van Haperen R., Scheek L., Jansen H., Ehnholm C., and van Tol A. Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of prebeta-high-density lipoproteins. Biochem. J. 360 (2001) 379-385
7. Jansen H., Verhoeven A.J., and Sijbrands E.J. Hepatic lipase: a pro- or anti-atherogenic protein?. J. Lipid Res. 43 (2002) 1352-1362
8. Jansen H. Hepatic lipase: friend or foe and under what circumstances?. Curr. Atheroscler. Rep. 6 (2004) 343-347
9. Santamarina-Fojo S., Gonzalez-Navarro H., Freeman L., Wagner E., and Nong Z. Hepatic lipase, lipoprotein metabolism, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1750-1754
10. Homanics G.E., de Silva H.V., Osada J., Zhang S.H., Wong H., Borensztajn J., and Maeda N. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J. Biol. Chem. 270 (1995) 2974-2980
11. Lie J., De Crom R., Van Gent T., Van Haperen R., Scheek L., Sadeghi-Niaraki F., and Van Tol A. Elevation of plasma phospholipid transfer protein increases the risk of atherosclerosis in spite of lowering apolipoprotein B containing lipoproteins. J. Lipid Res. 45 (2004) 805-811
12. Dallinga-Thie G.M., Zonneveld-de Boer A.J., van Vark-van der Zee L.C., van Haperen R., van Gent T., Jansen H., De Crom R., and van Tol A. Appraisal of hepatic lipase and lipoprotein lipase activities in mice. J. Lipid Res. 48 (2007) 2788-2791
13. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 (1959) 911-917
14. Lie J., De Crom R., Van Gent T., Van Haperen R., Scheek L., Lankhuizen I., and Van Tol A. Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion. J. Lipid Res. 43 (2002) 1875-1880
15. Groener J.E., da Col P.G., and Kostner G.M. A hyperalphalipoproteinaemic family with normal cholesteryl ester transfer/exchange activity. Biochem. J. 242 (1987) 27-31
16. Olivecrona G., and Olivecrona T. Triglyceride lipases and atherosclerosis. Curr. Opin. Lipidol. 6 (1995) 291-305
17. Foger B., Santamarina-Fojo S., Shamburek R.D., Parrot C.L., Talley G.D., and Brewer Jr. H.B. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J. Biol. Chem. 272 (1997) 27393-27400
18. Van Tol A., Jauhiainen M., De Crom R., and Ehnholm C. Role of phospholipid transfer protein in high-density lipoprotein metabolism: insights from studies in transgenic mice. Int. J. Tissue React. 22 (2000) 79-84
19. Jiang X.C., Qin S., Qiao C., Kawano K., Lin M., Skold A., Xiao X., and Tall A.R. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat. Med. 7 (2001) 847-852
20. Qiu S., Bergeron N., Kotite L., Krauss R.M., Bensadoun A., and Havel R.J. Metabolism of lipoproteins containing apolipoprotein B in hepatic lipase-deficient mice. J. Lipid Res. 39 (1998) 1661-1668
21. Mezdour H., Jones R., Dengremont C., Castro G., and Maeda N. Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice. J. Biol. Chem. 272 (1997) 13570-13575
22. Busch S.J., Barnhart R.L., Martin G.A., Fitzgerald M.C., Yates M.T., Mao S.J., Thomas C.E., and Jackson R.L. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J. Biol. Chem. 269 (1994) 16376-16382
23. Braschi S., Couture N., Gambarotta A., Gauthier B.R., Coffill C.R., Sparks D.L., Maeda N., and Schultz J.R. Hepatic lipase affects both HDL and ApoB-containing lipoprotein levels in the mouse. Biochim. Biophys. Acta 1392 (1998) 276-290
24. Ehnholm S., van Dijk K.W., van't Hof B., van der Zee A., Olkkonen V.M., Jauhiainen M., Hofker M., Havekes L., and Ehnholm C. Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice. J. Lipid Res. 39 (1998) 1248-1253
25. Yang X.P., Yan D., Qiao C., Liu R.J., Chen J.G., Li J., Schneider M., Lagrost L., Xiao X., and Jiang X.C. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1601-1607
26. Jacobs R.L., Devlin C., Tabas I., and Vance D.E. Targeted deletion of hepatic CTP:phosphocholine cytidylyltransferase alpha in mice decreases plasma high density and very low density lipoproteins. J. Biol. Chem. 279 (2004) 47402-47410
27. Watts G.F., Riches F.M., Humphries S.E., Talmud P.J., and van Bockxmeer F.M. Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity. J. Lipid Res. 41 (2000) 481-488
28. Barter P.J., and Rye K.A. Relationship between the concentration and antiatherogenic activity of high-density lipoproteins. Curr. Opin. Lipidol. 17 (2006) 399-403
29. Jansen H., van Tol A., and Hulsmann W.C. On the metabolic function of heparin-releasable liver lipase. Biochem. Biophys. Res. Commun. 92 (1980) 53-59
30. Lewis G.F. Determinants of plasma HDL concentrations and reverse cholesterol transport. Curr. Opin. Cardiol. 21 (2006) 345-352
31. Bamberger M., Glick J.M., and Rothblat G.H. Hepatic lipase stimulates the uptake of high density lipoprotein cholesterol by hepatoma cells. J. Lipid Res. 24 (1983) 869-876
32. van Tol A., van Gent T., and Jansen H. Degradation of high density lipoprotein by heparin-releasable liver lipase. Biochem. Biophys. Res. Commun. 94 (1980) 101-108